Testing effectiveness (Phase 2)Study completedNCT04984889What this trial is testingTAK-662 for Japanese Patients With Congenital Protein C DeficiencyWho this might be right forCongenital Protein C Deficiency Takeda 5
Early research (Phase 1)Study completedNCT00006509What this trial is testingThe Safety and Effectiveness of an HIV Vaccine for HIV-Positive Patients Receiving Anti-HIV Drugs for at Least 2 YearsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 12
Early research (Phase 1)Study completedNCT03409276What this trial is testingEvaluating the Safety and Immunogenicity of Env (A,B,C,A/E)/Gag (C) DNA and gp120 (A,B,C,A/E) Protein/GLA-SE HIV Vaccines, Given Individually or Co-administered, in Healthy, HIV-1-Uninfected AdultsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 60
Early research (Phase 1)Study completedNCT00000868What this trial is testingEvaluate the Safety and Effectiveness of HIV-1 LAI gp120 (an HIV Vaccine) Given With or Without HIV-1 MN rgp120 (Another HIV Vaccine) to HIV-Negative VolunteersWho this might be right forHIV InfectionsHIV Seronegativity National Institute of Allergy and Infectious Diseases (NIAID) 27
Not applicableStudy completedNCT03642678What this trial is testingDialysis Model for Outcome and Nutrition DecisionWho this might be right forProtein-Calorie Malnutrition An Hsin QingShui Clinic 422
Early research (Phase 1)Study completedNCT04927585What this trial is testingEvaluating the Safety and Immunogenicity of Polyvalent DNA/gp120 HIV Vaccine in Healthy, HIV-uninfected AdultsWho this might be right forHIV Infections Worcester HIV Vaccine 42
Early research (Phase 1)Study completedNCT00001026What this trial is testingA Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines in Vaccinia-Naive IndividualsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 56
Testing effectiveness (Phase 2)Ended earlyNCT04899232What this trial is testingAntithrombin III in Infectious Disease Caused by COVID-19Who this might be right forAntithrombin III DeficiencyCovid19 Enrique Ginzburg 52
Not applicableEnded earlyNCT05655546What this trial is testingImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised IndividualsWho this might be right forImmunodeficiencyImmunosuppressionHIV Infections+7 more Scripps Translational Science Institute 2,117
Not applicableUnknownNCT05679544What this trial is testingBiological Signatures Resulting From Occupational Exposure to Complex Mixtures of PAHsWho this might be right forMetabolic DisturbanceProtein DeficiencyGenotoxicity University Hospital, Grenoble 100
Not applicableStudy completedNCT03034044What this trial is testingPost-Marketing Surveillance To Observe Safety And Efficacy Of Xyntha Solofuse Prefilled SyringeWho this might be right forFactor VIII Deficiency, CongenitalFactor 8 Deficiency, CongenitalAutosomal Hemophilia A+2 more Pfizer 106
Not applicableUnknownNCT05426447What this trial is testingProtein and Performance (PROPER) in Endurance AthletesWho this might be right forDiet, HealthyProtein Deficiency University of Copenhagen 20
Not applicableStudy completedNCT03876301What this trial is testingLead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A ParticipantsWho this might be right forBlood Coagulation DisorderBlood Coagulation Disorders, InheritedCoagulation Protein Disorders+6 more Spark Therapeutics, Inc. 25
Large-scale testing (Phase 3)Looking for participantsNCT06954441What this trial is testingV-IMMUNE: A Novel Immunoglobulin Therapy for ImmunodeficiencyWho this might be right forImmunodeficienciesPrimary Immunodeficiencies (PID)Agammaglobulinemia On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA. 50
Large-scale testing (Phase 3)WithdrawnNCT00916656What this trial is testingFibrinogen Concentrate (Human) - Efficacy and Safety StudyWho this might be right forAfibrinogenemiaHypofibrinogenemiaFibrinogen Deficiency CSL Behring
Not applicableLooking for participantsNCT07097337What this trial is testingPoint of Care Fibrinogen Measurement in Trauma Patients in the Emergency DepartmentWho this might be right forTrauma Induced CoagulopathyTrauma CoagulopathyFibrinogen Deficiency+3 more Erasmus Medical Center 150
Not applicableStudy completedNCT02413905What this trial is testingCharacterizing the Gut Microbiota Alteration Associated With Severe Acute MalnutritionWho this might be right forSevere MalnutritionMalnutritionInfant Nutrition Disorders+3 more Institut Hospitalo-Universitaire Méditerranée Infection 100
Early research (Phase 1)Study completedNCT00000857What this trial is testingEvaluate the Effects of Interleukin-12 (rhIL-12) in HIV-Positive Patients With CD4 Cell Counts Less Than 50 Cells/mm3 or 300-500 Cells/mm3Who this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 65
Not applicableStudy completedNCT05661006What this trial is testingETOL-Elderly Study of the Efficiency of the Innovative Food Supplement in Elderly AdultsWho this might be right forVitamin d DeficiencyVitamin B 12 DeficiencyProtein Deficiency Institute of Nutrition, Slovenia (Nutris) 40
Not applicableEnded earlyNCT01782027What this trial is testingMendelian Reverse Cholesterol Transport StudyWho this might be right forCholesterol, HDLLipid Metabolism, Inborn ErrorsTangier Disease+2 more University of Pennsylvania 17